Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matteo Ceccarelli

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
JTO Clinical and Research Reports|April 4, 2022
RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With <i>EGFR</i>-Mutated Metastatic NSCLCMakoto Nishio, Kazuto Nishio, Martin Reck, et al.
BMC Cancer|March 30, 2013
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatmentsLucia Del Mastro, Alessandra Fabi, Mauro Mansutti, et al.
ACS Infectious Diseases|July 3, 2018
Getting Drugs into Gram-Negative Bacteria: Rational Rules for Permeation through General PorinsSilvia Acosta-Gutiérrez, Luana Ferrara, Monisha Pathania, et al.
Cells|March 25, 2022
Current Methods to Unravel the Functional Properties of Lysosomal Ion Channels and TransportersMargherita Festa, Velia Minicozzi, Anna Boccaccio, et al.
Cell Death & Disease|December 20, 2022
Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivoMagdalena Bachmann, Andrea Rossa, Tatiana Varanita, et al.
JAMA Network Open|October 13, 2021
Patient Perceptions and Knowledge of Ionizing Radiation From Medical ImagingLuca Bastiani, Fabio Paolicchi, Lorenzo Faggioni, et al.
Molecular Cancer Therapeutics|November 12, 2020
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue SarcomaJavier Martín-Broto, Antonio López Pousa, Andrew S Brohl, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
JTO Clinical and Research Reports|April 4, 2022
RELAY+: Exploratory Study of Ramucirumab Plus Gefitinib in Untreated Patients With <i>EGFR</i>-Mutated Metastatic NSCLCMakoto Nishio, Kazuto Nishio, Martin Reck, et al.
BMC Cancer|March 30, 2013
Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatmentsLucia Del Mastro, Alessandra Fabi, Mauro Mansutti, et al.
ACS Infectious Diseases|July 3, 2018
Getting Drugs into Gram-Negative Bacteria: Rational Rules for Permeation through General PorinsSilvia Acosta-Gutiérrez, Luana Ferrara, Monisha Pathania, et al.
Cells|March 25, 2022
Current Methods to Unravel the Functional Properties of Lysosomal Ion Channels and TransportersMargherita Festa, Velia Minicozzi, Anna Boccaccio, et al.
Cell Death & Disease|December 20, 2022
Pharmacological targeting of the mitochondrial calcium-dependent potassium channel KCa3.1 triggers cell death and reduces tumor growth and metastasis in vivoMagdalena Bachmann, Andrea Rossa, Tatiana Varanita, et al.
JAMA Network Open|October 13, 2021
Patient Perceptions and Knowledge of Ionizing Radiation From Medical ImagingLuca Bastiani, Fabio Paolicchi, Lorenzo Faggioni, et al.
Molecular Cancer Therapeutics|November 12, 2020
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue SarcomaJavier Martín-Broto, Antonio López Pousa, Andrew S Brohl, et al.
Pageof 11